6401 - 6425 of 8620 Results
Title
Year
- Effects of Gocovri (Amantadine) Extended-Release Capsules on Motor Aspects of Experiences of Daily Living in People with Parkinson’s Disease and Dyskinesia2021OPENTitle: Effects of Gocovri (Amantadine) Extended-Release Capsules on Motor Aspects of Experiences of Daily Living in People with Parkinson’s Disease and DyskinesiaJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 10Issue #: 2Start Page: 739End Page: 751Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-021-00256-1Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-021-00256-1.pdfCitation Count: 11
- Effects of Gocovri (Amantadine) Extended Release Capsules on Non-Motor Symptoms in Patients with Parkinson’s Disease and Dyskinesia2021OPENTitle: Effects of Gocovri (Amantadine) Extended Release Capsules on Non-Motor Symptoms in Patients with Parkinson’s Disease and DyskinesiaJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page: 307End Page: 320Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-021-00246-3Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-021-00246-3.pdfCitation Count: 13
- MicroRNA-7 Protects Against Neurodegeneration Induced by α-Synuclein Preformed Fibrils in the Mouse Brain2021OPENTitle: MicroRNA-7 Protects Against Neurodegeneration Induced by α-Synuclein Preformed Fibrils in the Mouse BrainJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 18Issue #: 4Start Page: 2529End Page: 2540Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s13311-021-01130-6Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-021-01130-6.pdfCitation Count: 20
- Selective blockade of the 5-HT3 receptor acutely alleviates dyskinesia and psychosis in the parkinsonian marmoset2020RESTRICTEDTitle: Selective blockade of the 5-HT3 receptor acutely alleviates dyskinesia and psychosis in the parkinsonian marmosetJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 182Issue #:Start Page: 108386End Page: 108386Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2020.108386Citation Count: 14
- Gait Deficits and Loss of Striatal Tyrosine Hydroxlase/Trk-B are Restored Following 7,8-Dihydroxyflavone Treatment in a Progressive MPTP Mouse Model of Parkinson’s Disease2020RESTRICTEDTitle: Gait Deficits and Loss of Striatal Tyrosine Hydroxlase/Trk-B are Restored Following 7,8-Dihydroxyflavone Treatment in a Progressive MPTP Mouse Model of Parkinson’s DiseaseJournal Name: NeurosciencePublisher: Elsevier BVVol: 433Issue #:Start Page: 53End Page: 71Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2020.02.046Citation Count: 39
-
OPENTitle: Enhanced Susceptibility of PINK1 Knockout Rats to α-Synuclein FibrilsJournal Name: NeurosciencePublisher: Elsevier BVVol: 437Issue #:Start Page: 64End Page: 75Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2020.04.032Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7510511Citation Count: 19
- Effects of subthalamic nucleus deep brain stimulation on neuronal spiking activity in the substantia nigra pars compacta in a rat model of Parkinson’s disease2020RESTRICTEDTitle: Effects of subthalamic nucleus deep brain stimulation on neuronal spiking activity in the substantia nigra pars compacta in a rat model of Parkinson’s diseaseJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 739Issue #:Start Page: 135443End Page: 135443Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2020.135443Citation Count: 9
- Early cognitive decline after bilateral subthalamic deep brain stimulation in Parkinson's disease patients with GBA mutations2020OPENTitle: Early cognitive decline after bilateral subthalamic deep brain stimulation in Parkinson's disease patients with GBA mutationsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 76Issue #:Start Page: 56End Page: 62Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.04.002Best OA location URL: http://www.prd-journal.com/article/S1353802020300973/pdfCitation Count: 46
- The challenge of developing adenosine A2A antagonists for Parkinson disease: Istradefylline, preladenant, and tozadenant2020OPENTitle: The challenge of developing adenosine A2A antagonists for Parkinson disease: Istradefylline, preladenant, and tozadenantJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 80Issue #:Start Page: S54End Page: S63Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.10.027Best OA location URL: https://doi.org/10.1016/j.parkreldis.2020.10.027Citation Count: 37
- Long-term evaluation of open-label pimavanserin safety and tolerability in Parkinson's disease psychosis2020RESTRICTEDTitle: Long-term evaluation of open-label pimavanserin safety and tolerability in Parkinson's disease psychosisJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 77Issue #:Start Page: 100End Page: 106Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.06.026Citation Count: 32
-
OPENTitle: Parkinson's disease motor subtype changes during 20 years of follow-upJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 76Issue #:Start Page: 104End Page: 107Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.05.024Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6980332Citation Count: 30
-
OPENTitle: SMPD1 variants do not have a major role in rapid eye movement sleep behavior disorderJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 93Issue #:Start Page: 142.e5End Page: 142.e7Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2020.04.005Best OA location URL: http://hdl.handle.net/11380/1206941Citation Count: 5
-
OPENTitle: Variants in the Niemann–Pick type C gene NPC1 are not associated with Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 93Issue #:Start Page: 143.e1End Page: 143.e4Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2020.03.021Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7302975Citation Count: 18
-
OPENTitle: Preexisting Bipolar Disorder Influences the Subsequent Phenotype of Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 12Start Page: 2840End Page: 2852Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28745Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28745Citation Count: 18
-
RESTRICTEDTitle: Multimodal Longitudinal Neurophysiological Investigations in Dopa‐Responsive DystoniaJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1986End Page: 1987Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28679Best OA location URL: https://doi.org/10.1002/mds.28679Citation Count: 4
-
OPENTitle: Scoring Algorithm‐Based Genomic Testing in Dystonia: A Prospective Validation StudyJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1959End Page: 1964Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28614Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28614Citation Count: 19
-
OPENTitle: A Novel Variant of ATP5MC3 Associated with Both Dystonia and Spastic ParaplegiaJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 2Start Page: 375End Page: 383Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28821Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8840961Citation Count: 13
-
RESTRICTEDTitle: Changes in Body Composition Before and After Parkinson's Disease DiagnosisJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 7Start Page: 1617End Page: 1623Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28536Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/10775470Citation Count: 19
-
RESTRICTEDTitle: Preferences for Communication About End‐of‐Life Care in Atypical ParkinsonismJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 9Start Page: 2116End Page: 2125Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28633Citation Count: 12
- Is Telemedicine the New Normal or Is the Office Visit Still the Movement Disorder Option of Choice?2021OPENTitle: Is Telemedicine the New Normal or Is the Office Visit Still the Movement Disorder Option of Choice?Journal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 7Start Page: 1481End Page: 1482Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28673Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28673Citation Count: 4
- Dysprosody in Isolated REM Sleep Behavior Disorder with Impaired Olfaction but Intact Nigrostriatal Pathway2021RESTRICTEDTitle: Dysprosody in Isolated REM Sleep Behavior Disorder with Impaired Olfaction but Intact Nigrostriatal PathwayJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 3Start Page: 619End Page: 623Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28873Citation Count: 10
- mTOR Inhibition with Sirolimus in Multiple System Atrophy: A Randomized, Double‐Blind, Placebo‐Controlled Futility Trial and 1‐Year Biomarker Longitudinal Analysis2022OPENTitle: mTOR Inhibition with Sirolimus in Multiple System Atrophy: A Randomized, Double‐Blind, Placebo‐Controlled Futility Trial and 1‐Year Biomarker Longitudinal AnalysisJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 4Start Page: 778End Page: 789Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28923Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9018525Citation Count: 23
- Validation of the Arabic Version of the Movement Disorder Society‐Unified Parkinson's Disease Rating Scale2022RESTRICTEDTitle: Validation of the Arabic Version of the Movement Disorder Society‐Unified Parkinson's Disease Rating ScaleJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 4Start Page: 826End Page: 841Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28905Citation Count: 6
- De Novo and Dominantly Inherited SPTAN1 Mutations Cause Spastic Paraplegia and Cerebellar Ataxia2022OPENTitle: De Novo and Dominantly Inherited SPTAN1 Mutations Cause Spastic Paraplegia and Cerebellar AtaxiaJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 6Start Page: 1175End Page: 1186Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28959Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9232883Citation Count: 21
-
RESTRICTEDTitle: Implications of DNA Methylation in Lewy Body PathologyJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 1Start Page: 25End Page: 25Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29290Citation Count: 0